- April 11, 2025
After nearly three years of backorders and pharmacy scrambles, the high-demand weight-loss drugs Ozempic, Wegovy, and Mounjaro are finally back in full supply. The FDA recently declared an end to the nationwide shortage of their active ingredients, semaglutide and tirzepatide. Martin Binks, chair of the Department of Nutrition and Food Studies at George Mason University and a researcher and clinician with expertise in obesity, explains what this moment means for patients, providers, and public health.
- April 19, 2022
Mason professor Kerri LaCharite writes and teaches about sustainable food systems, urban agriculture and the effects of agriculture-based learning on eating behaviors.
- Thu, 09/24/2020 - 12:26
Pilot initiative builds ability to deliver testing, contact tracing, and stress management protocols among health care providers, with goal of rapidly scaling to other sectors.
- Thu, 06/25/2020 - 09:41
George Mason University study finds cancer survivors estimate a higher than actual intake of fruits, vegetables, and whole grains, providing opportunities for interventions to improve cancer survival rates.
- Fri, 02/14/2020 - 17:05
Dr. Katherine M. Keyes was the second speaker in the College of Health and Human Services Dean’s Seminar Series on January 27, 2020. Keyes is an associate professor of epidemiology and co-director of the Psychiatric Epidemiology Training Program at Columbia University’s Mailman School of Public Health. She shared her research and the current understanding on the increase of depressive symptoms and suicide in adolescent girls.